A comparison of glypican-3 with alpha-fetoprotein as a serum marker for hepatocellular carcinoma: a

来源 :中华医学会第十六次全国病毒性肝炎及肝病学术会议 | 被引量 : 0次 | 上传用户:lyfqxx3
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Baekgrounds Glypican-3 (GPC-3) has been reported as one of the most promising serum markers for hepatocellular carcinoma (HCC), while several studies have conflicting Conclusions for the diagnostic accuracy between GPC-3 and alpha-fetoprotein (AFP).Methods Studies that explored the diagnostic value of GPC-3 and AFP in HCC were searched in MEDLINE, EMBASE, PUBMED, the Cochrane Library and Chinese BioMedical Literature Database (CBM).Sensitivity, specificity and other measures about the accuracy of serum GPC-3 and AFP in the diagnosis of HCC were pooled using random-effects models.Summary receiver operating characteristic curve (sROC) analysis was used to summarize the overall test performance.Results Ten studies were included in our meta-analysis.The pooled sensitivity for AFP and GPC-3 are: AFP 51.9% (95% confidence interval (CI) : 0.47-0.56), GPC-3 59.2% (95% CI: 0.55-0.63) ; while the pooled specificity for AFP and GPC-3 are: AFP 94% (95%CI: 92.1% to 95.6%), GPC-3 84.8% (95%CI: 82% to 87.3%).The pooled diagnostic odds ratio (DOR): AFP 23.4 (95%CI: 10.3-53.2), GPC-3 17.99 (95%CI: 5.4-60.4).Area under sROC for AFP and GPC-3 are the same as 0.81 (95% CI: 0.77-0.84)Conclusions GPC-3 is comparable to AFP as a serum marker for the diagnosis of HCC, combination of AFP and GPC-3 can elevate the sensitivity of diagnosis.
其他文献
Background Hepatocellular carcinoma (HCC) is one of the most common malignant tumors.This particular type of carcinoma has poor survival rate and high post operation recurrence rate.Multiple factors a
会议
Background Vascular endothelial growth factor (VEGF) is an important signaling protein involved in both vasculogenesis (de novo formation of embryonic circulatory system) and angiogenesis (growth of b
会议
Background Forkhead box G1 (FOXG1) is a member of Fox transcription factors family involved in the regulation of stem cell.However, the role of FOXG1 in hepatocellular carcinogenesis (HCC) is largely
会议
Objective This study aim is to investigate using of bone marrow mesenchymal stem cells (BMSC) genetically engineered to produce interferon-b (IFN-b) as a gene delivery system to treat hepatocellular c
会议
目的 非酒精性脂肪性肝病(NAFLD)尤其是其关键阶段非酒精性脂肪性肝炎(NASH)已成为全球最重要的公共健康问题之一.病理检查是NASH诊断的"金标准",但属有创诊断,不被患者接受.无创诊断是NASH诊治的必然发展方向,但目前缺乏令人满意的无创诊断、预测NASH指标.本研究探究血清白介素-1受体拮抗剂(IL-1RA)与NAFLD进展的相关性,无创性预测诊断NASH.方法 选取确诊NAFLD病例6
会议
Objective To construct an eukaryotic expression vector of RNA interference specific for Smad3, and to evaluate the effect of this siRNA on hepatic stellate cells in vitro.Methods To design psilencer3.
会议
Object To observe the levels of serum I-FABP, MLT, GAS of the acute liver failure rats and to analysis the relationship between these indicators and gastrointestinal dysfunction of these rats, and pro
会议
Objective Patients who have not obtained the effective suppression of HBV cannot have an improvement in liver histology.The combination antiviral therapy of lamivudine plus adefovir is the recommended
会议
Background HBeAg-negative chronic hepatitis B (CHB) patients have active liver disease with a high risk of progression to decompensated cirrhosis and hepatocellular carcinoma.The management strategy o
会议
Objective To observe the expression of fatty acid synthase (FASN) in alcohol-induced liver injury in mice, and investigate the possible mechanism of EGFR in the process.Methods Primary mice hepatocyte
会议